| PERIOD ENDING | 31-Mar-99 | | Total Revenue | 346 | | Cost of Revenue | 405 | | | Gross Profit | (59) | | | Operating Expenses | | Research Development | 307 | | Selling General and Administrative | 1,288 | | Non Recurring |
-
| | Others | 386 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | (2,040) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| | Earnings Before Interest And Taxes | (2,040) | | Interest Expense | 271 | | Income Before Tax | (2,311) | | Income Tax Expense |
-
| | Minority Interest |
-
| | | | Net Income From Continuing Ops | (2,311) | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | (2,311) | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | ($2,311) |
|
0.02% Nasdaq 0.00%
Income Statement
